Akebia Therapeutics Inc (AKBA)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -61.264 | -23.151 | -21.104 | -31.64 | -54.186 | -48.362 | -21.1 | -17.497 |
Return on Equity (%) | -136.348 | -82.063 | -38.024 | -54.267 | -119.387 | -174.553 | -215.767 | 488.89 |
Return on Invested Capital (%) | -138.921 | -86.914 | -46.002 | -55.936 | -65.487 | -137.82 | -133.044 | -167.114 |
Operating Margin (%) | -8843.453 | -43.214 | -82.759 | -85.459 | -126.846 | -123.095 | -26.273 | -23.58 |
Net Profit Margin (%) | -8843.453 | -43.214 | -69.118 | -83.48 | -129.85 | -132.429 | -31.634 | -26.68 |
Book Value Per Share | 1.764 | 2.506 | 2.162 | 0.399 | 0.327 | -0.49 | -0.64 | -0.667 |
Earnings Per Share | -3.515 | -1.615 | -1.228 | -2.298 | -2.59 | -1.598 | -0.503 | -0.276 |
Cash Per Share | 4.851 | 1.473 | 0.895 | 1.212 | 1.544 | 0.846 | 0.492 | 0.228 |
Working Capital Per Share | 4.714 | 4.495 | 1.733 | 0.833 | 1.245 | 0.088 | 0.327 | 0.097 |
Operating Profit Per Share | 0.04 | 3.738 | 1.724 | 1.858 | 0.989 | 0.555 | 1.335 | 0.839 |
EBIT Per Share | -3.515 | -1.615 | -1.471 | -2.353 | -2.59 | -1.598 | -0.503 | -0.276 |
EBITDA Per Share | -3.515 | -1.615 | -1.471 | -2.353 | -2.59 | -1.598 | -0.503 | -0.276 |
Free Cash Flow Per Share | -3.454 | -1.594 | -1.235 | -2.561 | -2.815 | -1.812 | -0.707 | -0.475 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 38.62M | 47.61M | 116.89M | 121.68M | 148.07M | 177M | N/A | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -61.445 | N/A | N/A | N/A | -47.496 | N/A | N/A |
Net Profit Margin (%) | N/A | -65.335 | N/A | N/A | N/A | -55.157 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 405.82M |
Price to Earnings Ratio | -8.07 |
Price to Sales Ratio | 2.15 |
Price to Cash Ratio | 9.76 |
Price to Book Ratio | -13.7 |
Dividend Yield | - |
Shares Outstanding | 218.18M |
Average Volume (1 week) | 2.39M |
Average Volume (1 Month) | 2.16M |
52 Week Change | 62.18% |
52 Week High | 2.48 |
52 Week Low | 0.80 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.